Publications by authors named "Ignace Billiet"

Claim this Profile
M
Multicentre, prospective study on local treatment of metastatic prostate cancer (LoMP study).
Sarah Buelens, Filip Poelaert, Tom Claeys, Elise De Bleser, Bert Dhondt, Ignace Billiet

BJU Int· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization and Operative Influence of Renal Mass Biopsy in the Small Renal Mass: Analysis from the Clinical Research Office of the Endourological Society Small Renal Mass registry.
Mohammed Shahait, Stephen Jackman, Jaime Landman, Eric Lechevallier, Ignace Billiet

J Endourol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Trial-Based Cost-Utility Analysis of Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer.
Elise De Bleser, Ruben Willems, Karel Decaestecker, Lieven Annemans, Aurélie De Bruycker, Ignace Billiet

Cancers (Basel)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introducing new technology safely into urological practice.
Siska Van Bruwaene, Benjamin Namdarian, Ben Challacombe, Ben Eddy, Ignace Billiet

World J Urol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.
Piet Ost, Dries Reynders, Karel Decaestecker, Valérie Fonteyne, Nicolaas Lumen, Ignace Billiet

J Clin Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy.
Aurélie De Bruycker, Bieke Lambert, Tom Claeys, Louke Delrue, Chamberlain Mbah, Ignace Billiet

BJU Int· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
I brachytherapy in younger prostate cancer patients : Outcomes in low- and intermediate-risk disease.
Isabelle Kindts, Karin Stellamans, Ignace Billiet, Hans Pottel, Antoon Lambrecht

Strahlenther Onkol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoreductive Prostatectomy for Metastatic Prostate Cancer: First Lessons Learned From the Multicentric Prospective Local Treatment of Metastatic Prostate Cancer (LoMP) Trial.
Filip Poelaert, Caroline Verbaeys, Bernard Rappe, Bart Kimpe, Ignace Billiet

Urology· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial.
Maria E Goossens, Maurice P Zeegers, Hendrik van Poppel, Steven Joniau, Koen Ackaert, Ignace Billiet

Eur J Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Body Image in Patients with Prostate Cancer over 2 Years of Treatment with a Gonadotropin-Releasing Hormone Analogue (Triptorelin): Results from a Belgian Non-Interventional Study.
Hans van den Driessche, Pieter Mattelaer, Peter van Oyen, Wouter Marchand, Ovadia Bar-Moshé, Ignace Billiet

Drugs Real World Outcomes· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Multimedia Education with 3D Animation Impact Quality and Duration of Urologists' Interactions with their Prostate Cancer Patients?
Alexandre Peltier, Fouad Aoun, Filip Ameye, Robert Andrianne, Gert De Meerleer, Ignace Billiet

Adv Ther· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial.
Karel Decaestecker, Gert De Meerleer, Filip Ameye, Valerie Fonteyne, Bieke Lambert, Ignace Billiet

BMC Cancer· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apples and oranges: comparison of treatment methods for prostate cancer using biochemical recurrence as an endpoint.
Peter Grimm, Ignace Billiet, David Bostwick

BJU Int· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium.
Maria E Goossens, Frank Buntinx, Steven Joniau, Koen Ackaert, Filip Ameye, Ignace Billiet

BMC Urol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.
Peter Grimm, Ignace Billiet, David Bostwick, Adam P Dicker, Steven Frank

BJU Int· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.
Michel Bolla, Geertjan Van Tienhoven, Padraig Warde, Jean Bernard Dubois, René-Olivier Mirimanoff, Ignace Billiet

Lancet Oncol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Greet Swinnen, Alex Maes, Hans Pottel, Alain Vanneste, Ignace Billiet

Eur Urol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: results of a Belgian retrospective multicentre survey.
Peter Schatteman, Charles Chatzopoulos, Christophe Assenmacher, Luc De Visscher, Jean-Luc Jorion, Ignace Billiet

Eur Urol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis